BACKGROUND: Oxidative stresses including cigarette smoking are implicated in the pathogenesis of cerebrovascular diseases, which are associated with pneumonia because of frequent aspiration. Haem oxygenase-1 (HO-1) acts in cytoprotection against oxidants, provides anti-inflammatory effects, and inhibits atherogenesis. A (GT)(n) dinucleotide repeat in the human HO-1 promoter modulates HO-1 gene expression and shows length polymorphism, which is grouped into three classes: class S (<27 repeats), class M (> or = 27, <33 repeats), and class L (> or = 33 repeats) alleles. OBJECTIVE: To investigate the correlation between the HO-1 gene polymorphism and development of pneumonia in elderly Japanese. METHODS: The length of the (GT)n repeats was analysed in 200 elderly patients with pneumonia and 200 control subjects. The association of the HO-1 gene polymorphism with risk of pneumonia was estimated by logistic regression. RESULTS: The proportion of allele frequencies in class L, and the proportion of genotypic frequencies in the L-allele carriers (L/L, L/M, and L/S), was significantly higher in patients with pneumonia than in controls (20% v 10% in class L, and 34% v 18% in L-allele carriers). After adjustment for potentially confounding factors, both cerebrovascular disorders and HO-1 gene L-allele carriers were significant and independent risk factors for pneumonia. The adjusted odds ratio for L-allele carriers v non-L-allele carrier was 2.1 (95% confidence interval, 1.2 to 3.6). CONCLUSIONS: The large size of a (GT)n repeat in the HO-1 gene promoter may be associated with susceptibility to pneumonia in the older Japanese population.
BACKGROUND: Oxidative stresses including cigarette smoking are implicated in the pathogenesis of cerebrovascular diseases, which are associated with pneumonia because of frequent aspiration. Haem oxygenase-1 (HO-1) acts in cytoprotection against oxidants, provides anti-inflammatory effects, and inhibits atherogenesis. A (GT)(n) dinucleotide repeat in the humanHO-1 promoter modulates HO-1 gene expression and shows length polymorphism, which is grouped into three classes: class S (<27 repeats), class M (> or = 27, <33 repeats), and class L (> or = 33 repeats) alleles. OBJECTIVE: To investigate the correlation between the HO-1 gene polymorphism and development of pneumonia in elderly Japanese. METHODS: The length of the (GT)n repeats was analysed in 200 elderly patients with pneumonia and 200 control subjects. The association of the HO-1 gene polymorphism with risk of pneumonia was estimated by logistic regression. RESULTS: The proportion of allele frequencies in class L, and the proportion of genotypic frequencies in the L-allele carriers (L/L, L/M, and L/S), was significantly higher in patients with pneumonia than in controls (20% v 10% in class L, and 34% v 18% in L-allele carriers). After adjustment for potentially confounding factors, both cerebrovascular disorders and HO-1 gene L-allele carriers were significant and independent risk factors for pneumonia. The adjusted odds ratio for L-allele carriers v non-L-allele carrier was 2.1 (95% confidence interval, 1.2 to 3.6). CONCLUSIONS: The large size of a (GT)n repeat in the HO-1 gene promoter may be associated with susceptibility to pneumonia in the older Japanese population.
Authors: Robert Ollinger; Martin Bilban; Anna Erat; Alberto Froio; James McDaid; Shivraj Tyagi; Eva Csizmadia; Aurelio V Graça-Souza; Angela Liloia; Miguel P Soares; Leo E Otterbein; Anny Usheva; Kenichiro Yamashita; Fritz H Bach Journal: Circulation Date: 2005-08-08 Impact factor: 29.690
Authors: D Doberer; A Haschemi; M Andreas; T-C Zapf; B Clive; M Jeitler; H Heinzl; O Wagner; M Wolzt; M Bilban Journal: Br J Pharmacol Date: 2010-12 Impact factor: 8.739
Authors: M Hausmann; G Paul; S Kellermeier; I Frey; J Schölmerich; W Falk; K Menzel; M Fried; H Herfarth; G Rogler Journal: Clin Exp Immunol Date: 2008-05-05 Impact factor: 4.330
Authors: Chau-Chyun Sheu; Rihong Zhai; Zhaoxi Wang; Michelle N Gong; Paula Tejera; Feng Chen; Li Su; B Taylor Thompson; David C Christiani Journal: Intensive Care Med Date: 2009-06-13 Impact factor: 17.440
Authors: Michael Walther; Adam De Caul; Peter Aka; Madi Njie; Alfred Amambua-Ngwa; Brigitte Walther; Irene M Predazzi; Aubrey Cunnington; Susanne Deininger; Ebako N Takem; Augustine Ebonyi; Sebastian Weis; Robert Walton; Sarah Rowland-Jones; Giorgio Sirugo; Scott M Williams; David J Conway Journal: PLoS Pathog Date: 2012-03-15 Impact factor: 6.823
Authors: Satindra Gahlot; Najmunnisa Nasreen; Judith A Johnson; Steven A Sahn; Kamal A Mohammed Journal: PLoS One Date: 2017-01-04 Impact factor: 3.240
Authors: Alexander J Gill; Rolando Garza; Surendra S Ambegaokar; Benjamin B Gelman; Dennis L Kolson Journal: J Neuroinflammation Date: 2018-03-06 Impact factor: 8.322